Correlation Between Oncternal Therapeutics and Aditxt

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Aditxt Inc, you can compare the effects of market volatilities on Oncternal Therapeutics and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Aditxt.

Diversification Opportunities for Oncternal Therapeutics and Aditxt

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Oncternal and Aditxt is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Aditxt go up and down completely randomly.

Pair Corralation between Oncternal Therapeutics and Aditxt

Given the investment horizon of 90 days Oncternal Therapeutics is expected to under-perform the Aditxt. In addition to that, Oncternal Therapeutics is 1.2 times more volatile than Aditxt Inc. It trades about -0.26 of its total potential returns per unit of risk. Aditxt Inc is currently generating about -0.28 per unit of volatility. If you would invest  72.00  in Aditxt Inc on August 28, 2024 and sell it today you would lose (32.00) from holding Aditxt Inc or give up 44.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Oncternal Therapeutics  vs.  Aditxt Inc

 Performance 
       Timeline  
Oncternal Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncternal Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Aditxt Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aditxt Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Oncternal Therapeutics and Aditxt Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncternal Therapeutics and Aditxt

The main advantage of trading using opposite Oncternal Therapeutics and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.
The idea behind Oncternal Therapeutics and Aditxt Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios